The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Drug Manufacturers - General industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
13 of 153
P/E 24.7 vs period average 21.2 Richer than its history
Ranked among 15 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/15 | ![]() | $64.72 | 14.3 | 77 | 27 | 58 | 81 |
| 2/15 | ![]() | $72.66 | 12.0 | 89 | 49 | 73 | 77 |
| 3/15 | ![]() | $1185.71 | 39.7 | 8 | 100 | 92 | 73 |
| 4/15 | ![]() | $52.96 | 15.0 | 79 | 68 | 56 | 71 |
| 5/15 | ![]() | $246.04 | 69.5 | 16 | 70 | 84 | 65 |
| 6/15 | ![]() | $156.33 | 23.5 | 34 | 35 | 76 | 61 |
| 7/15 | ![]() | $13.60 | 17.4 | 95 | 13 | 37 | 56 |
| 8/15 | ![]() | $410.94 | 25.5 | 25 | 56 | 48 | 55 |
| 9/15 | ![]() | $43.46 | 23.0 | 87 | 24 | 31 | 45 |
| 10/15 | ![]() | $128.57 | 102.0 | 23 | 41 | 39 | 42 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $9B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $20B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.4% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks